Susquehanna International Group, LLP Theratechnologies Inc. Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.78 - $1.01 $6,470 - $8,377	8,295 Added 45.94%	26,352 $22,000
Q1 2023 May 16, 2023	BUY	$0.72 - $1.12 $13,001 - $20,223	18,057 New	18,057 $14,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $3.76 $87,754 - $112,999	30,053 New	30,053 $91,000
Q3 2020 Nov 16, 2020	SELL	$1.96 - $2.92 $99,274 - $147,898	-50,650 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.58 - $2.86 $171,020 - $309,569	-108,241 Reduced 68.12%	50,650 $102,000
Q1 2020 May 15, 2020	BUY	$1.43 - $3.23 $155,163 - $350,474	108,506 Added 215.35%	158,891 $254,000
Q4 2019 Feb 14, 2020	BUY	$2.74 - $4.2 $138,054 - $211,617	50,385 New	50,385 $166,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $170M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.